Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Strategy

Biohaven’s Nurtec May Be First Migraine Drug For Acute Treatment And Prevention

Approved in February as an on-demand remedy, Nurtec will be filed for migraine prevention after success in Phase III. It could be the first oral preventive therapy and first dual purpose migraine drug.

Neurology Clinical Trials

A Backstage View Of Roche’s Recent Collaborations

In an exclusive interview, Barbara Lueckel, global head of research technologies at Roche Pharma Partnering, talks about the rationale behind the 2020 deals with Bicycle Therapeutics and Nimble Therapeutics. She gives insight into how deal makers are shifting gears to make deals happen in the challenging environment of the global coronavirus pandemic.

Business Strategies Companies

AZ Prioritizes Protection With COVID-19 Mask Donations

AstraZeneca is aiding the effort to protect healthcare workers against coronavirus with the necessary equipment . It is also set to unveil plans for new diagnostic testing and advancing development of a monoclonal antibody treatment to prevent COVID-19.

Coronavirus COVID-19 Strategy

Case Grows For Bayer's Old Anti-Malarial To Treat COVID-19

Bayer's anti-malaria therapy chloroquine is being touted as a cheap, safe and effective drug for coronavirus. However the company's product is only made in Pakistan and a variety of import and export agreements need to be in place for other countries to get hold of it.

Coronavirus COVID-19 Strategy

Coronavirus Actions: How Pharma In India Is Handling Safety, Business Continuity

Scrip contacted a cross section of pharma firms in India to get a sense of how they are handling the extraordinary work-operations-employee well-being situation amid the coronavirus outbreak. Work from home mandates, deploying digital tools wherever possible, cut-back in field activities and daily temperature checks at sites are some of the initiatives set in motion.

Commercial Coronavirus COVID-19

CureVac’s German Owner Rejects US Coronavirus Vaccine Grab

Dietmar Hopp, 80% shareholder of German mRNA company CureVac, has rejected the possibility that the company would sign an exclusive deal with the US for its investigational coronavirus vaccine.

Coronavirus COVID-19 Companies

McKinsey Execs On Expanding Pharma’s Digital Push, Lessons From Amazon

Two McKinsey & Company executives share their views on pharma’s digital trajectory, including the role of manufacturing ‘lighthouses’ and opportunities to deploy digital and analytical tools across the entire value chain for both innovator and generic firms. They see Amazon’s playbook on leveraging digital technology as holding some interesting lessons for pharma.

Commercial Digital Health

Interview: UK Initiative Bids To Boost Access To Cancer Clinical Trials

The Christie cancer hospital in Manchester has linked up with Innovative Trials to try and get more minority and socially-deprived communities into clinical studies.

Clinical Trials Cancer

Orexo Files Alcohol Abuse Digital Therapy With US FDA

The Swedish firm is taking a multifaceted approach to treating substance use disorders such as alcohol addiction, by offering both medication and psycho-social support.

Digital Health Strategy
See All